巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    ICU Medical

    ICUI
    154.620
    2.590
    1.70%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・ICU Medical - 延遲價格・最後更新於 23/09 12:00
    最高位
    155.090
    最低位
    150.700
    開市價
    --
    前收市價
    152.030
    成交量(千)
    18.06
    成交額(百萬)
    25.07
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    3,695.32
    市盈率
    359.580
    息率
    --
    差價
    --
    52週高低
    251.770 - 149.870
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    ICU Medical
    證券代碼
    ICUI.US
    所屬板塊
    Medical Instruments & Supplies
    公司業務
    ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
    發行量
    23896032
    公司總部
    951 Calle Amanecer
    公司網址
    https://www.icumed.com
    公司電郵
    ir@icumed.com
    公司電話
    +1 949 366-2183
    暫無內容

    關於

    ICU Medical(ICUI.US)所屬的行業板塊為Medical Instruments & Supplies。
    ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
    詳細公司背景可參考: https://www.icumed.com